STAT3 and benign prostatic hyperplasia: Strong nuclear immunoreactivity for STAT3 and STAT5A were observed in 93% (n=14) and 80% (n=12) of CRPC cases, respectively, whereas only one (7%) BPH case showed strong STAT3 staining (Figure 1A, 1B, respectively).